Open access · OA
via Europe PMC
Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration.
Biomolecules & therapeutics · 2026
Abstract
Recent technological advancements and environmental shifts have reshaped the therapeutic landscape of human diseases, driving a transition from merely understanding pathogenesis to developing precise and targeted therapeutic solutions. While the 2025 Special Issue focused on identifying emerging risk factors, the 2026 Special Issue (Vol. 34, No. 1) pivots toward concrete methodological innovations and advanced therapeutic interventions. This issue presents a curated collection of ten distinguished articles organized around three core themes. First, in the field of oncology and drug resistance, studies investigate transglutaminase 2 (TG2)-mediated autophagy(definition) and ferroptosis as strategies to overcome therapeutic resistance, alongside advances in CAR-T cell engineering and the integration of artificial intelligence (AI) with robotic surgery to enable precision medicine. Second, addressing degenerative and metabolic diseases, contributions elucidate the role of Wnt/β-catenin signaling in osteoporosis, recent therapeutic advances in knee osteoarthritis, mechanisms underlying drug-induced senescence(definition), and the application of gene-editing technologies in iPSC-derived hepatic models. Finally, investigations into the neuro-immune axis highlight the dual roles of adaptive immunity in Alzheimer's disease and evaluate novel pharmacological modulators targeting the kynurenine-aryl hydrocarbon receptor (AhR) axis. Collectively, this Special Issue delivers groundbreaking insights and innovative strategies aimed at restoring biological homeostasis and overcoming intractable diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.4062/biomolther.2025.008
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
HJ, K., & CH., L. (2026). Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration. <em>Biomolecules & therapeutics</em>. https://doi.org/10.4062/biomolther.2025.008
Vancouver
HJ K, CH. L. Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration. Biomolecules & therapeutics. 2026. doi:10.4062/biomolther.2025.008.
BibTeX
@article{ko2026Naviga,
title = {Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration.},
author = {Ko HJ and Lee CH.},
journal = {Biomolecules & therapeutics},
year = {2026},
doi = {10.4062/biomolther.2025.008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advances in biogerontology 2026
Citation only
Current advances in drug discovery for aging
Theranostics 2023
Open access · CC-BY
Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation
Signal Transduction and Targeted Therapy 2024
Open access · CC-BY
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
biorxiv 2025
Preprint · CC-BY
Cycling Molecular Assemblies for Selective Cancer Cell Golgi Disruption
IRCCS Centro San Giovanni di Dio Fatebenefratelli 2026
Open access · US-GOV
Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)
US Department of Veterans Affairs 1999
Open access · US-GOV